Understanding dendritic cell biology and its role in immunological disorders through proteomic profiling

Proteomics - Clinical Applications

Volumn 4, Issue 2, 2010, Pages 190-203

  Ferreira, Gabriela Bomfim ^a   Mathieu, Chantal ^a   Overbergh, Lut ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Dendritic cell; Immunological disorders; Proteomics

Indexed keywords

B7 ANTIGEN; CALCIUM BINDING PROTEIN; CATHEPSIN; CD28 ANTIGEN; CD86 ANTIGEN; CD9 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CYTOSOL AMINOPEPTIDASE; FATTY ACID BINDING PROTEIN; GAMMA INTERFERON; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANGANESE SUPEROXIDE DISMUTASE; PEROXIREDOXIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; THIOREDOXIN 1; TUMOR NECROSIS FACTOR ALPHA;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL INTERACTION; CELL LYSATE; CELL MATURATION; DENDRITIC CELL; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CELL EXTRACTS; CELL FRACTIONATION; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOLOGIC FACTORS; PROTEOMICS;

EID: 77951930636     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.200900162     Document Type: Review

References (117)

1. Steinman, R.M., Cohn, Z.A., Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 1973, 137, 1142-1162.
2. Trinchieri, G., Pillars of immunology: The birth of a cell type. J. Immunol. 2007, 178, 3-4.
3. Mellman, I., Steinman, R.M., Dendritic cells: specialized and regulated antigen processing machines. Cell 2001, 106, 255-258.
4. Mellman, I., Turley, S.J., Steinman, R.M., Antigen processing for amateurs and professionals. Trends Cell Biol. 1998, 8, 231-237.
5. Leon, B., Lopez-Bravo, M., Ardavin, C., Monocyte-derived dendritic cells. Semin. Immunol. 2005, 17, 313-318.
6. Ardavin, C., Martinez del Hoyo, G., Martin, P., Anjuere, F. et al., Origin and differentiation of dendritic cells. Trends Immunol. 2001, 22, 691-700.
7. Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C. et al., CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J. Exp. Med. 1996, 184, 695-706.
8. Sato, K., Fujita, S., Dendritic cells: Nature and classification. Allergol. Int. 2007, 56, 183-191.
9. Ueno, H., Klechevsky, E., Morita, R., Aspord, C. et al., Dendritic cell subsets in health and disease. Immunol. Rev. 2007, 219, 118-142.
10. Barchet, W., Cella, M., Colonna, M., Plasmacytoid dendritic cells-virus experts of innate immunity. Semin. Immunol. 2005, 17, 253-261.
11. Sallusto, F., Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994, 179, 1109-1118.
12. Bender, A., Sapp, M., Schuler, G., Steinman, R.M. et al., Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 1996, 196, 121-135.
13. Romani, N., Reider, D., Heuer, M., Ebner, S.et al., Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 1996, 196, 137-151.
14. Hawiger, D., Inaba, K., Dorsett, Y., Guo, M. et al., Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 2001, 194, 769-779.
15. Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A. et al., Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 2001, 193, 1285-1294.
16. Janeway, Jr C. A., Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 1989, 54, 1-13.
17. Blander, J.M., Medzhitov, R., Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006, 440, 808-812.
18. West, A.P., Koblansky, A.A., Ghosh, S., Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 2006, 22, 409-437.
19. West, M.A., Wallin, R.P., Matthews, S.P., Svensson, H.G. et al., Enhanced dendritic cell antigen capture via tolllike receptor-induced actin remodeling. Science 2004, 305, 1153-1157.
20. Banchereau, J., Steinman, R.M., Dendritic cells and the control of immunity. Nature 1998, 392, 245-252.
21. Heufler, C., Koch, F., Stanzl, U., Topar, G. et al., Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 1996, 26, 659-668.
22. Penna, G., Vulcano, M., Sozzani, S., Adorini, L., Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum. Immunol. 2002, 63, 1164-1171.
23. Tang, H.L., Cyster, J.G., Chemokine up-regulation and activated T cell attraction by maturing dendritic cells. Science 1999, 284, 819-822.
24. Yanagihara, S., Komura, E., Nagafune, J., Watarai, H. et al., EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 1998, 161, 3096-3102.
25. Adema, G.J., Hartgers, F., Verstraten, R., de Vries, E. et al., A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 1997, 387, 713-717.
26. Brocker, T., Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J. Exp. Med. 1997, 186, 1223-1232.
27. Granucci, F., Zanoni, I., Feau, S., Ricciardi-Castagnoli, P., Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity. EMBO J. 2003, 22, 2546-2551.
28. Banchereau, J., Briere, F., Caux, C., Davoust, J. et al., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18, 767-811.
29. Reis e Sousa, C., Dendritic cells in a mature age. Nat. Rev. Immunol. 2006, 6, 476-483.
30. Keir, M.E., Sharpe, A.H., The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 2005, 204, 128-143.
31. Kapsenberg, M.L., Dendritic-cell control of pathogendriven T-cell polarization. Nat. Rev. Immunol. 2003, 3, 984-993.
32. Zhu, J., Paul, W.E., CD4 T cells: fates, functions, and faults. Blood 2008, 112, 1557-1569.
33. Fiorentino, D.F., Bond, M.W., Mosmann, T.R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170, 2081-2095.
34. Weaver, C.T., Hatton, R.D., Mangan, P.R., Harrington, L.E., IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 2007, 25, 821-852.
35. Harrington, L.E., Hatton, R.D., Mangan, P.R., Turner, H. et al., Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6, 1123-1132.
36. Sakaguchi, S., Animal models of autoimmunity and their relevance to human diseases. Curr. Opin. Immunol. 2000, 12, 684-690.
37. Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A.H. et al., Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 2002, 80, 477-483.
38. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J. et al., Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 1997, 159, 4772-4780.
39. de Jong, E.C., Vieira, P.L., Kalinski, P., Kapsenberg, M.L., Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J. Leukoc. Biol. 1999, 66, 201-204.
40. Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S. et al., Regulatory T cells induced by 1 alpha, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 2001, 167, 1945-1953.
41. Sato, K., Yamashita, N., Baba, M., Matsuyama, T., Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003, 101, 3581-3589.
42. Vosters, O., Neve, J., De Wit, D., Willems, F. et al., Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory t cells. Transplantation 2003, 75, 383-389.
43. Wang, B., Morinobu, A., Horiuchi, M., Liu, J. et al., Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cell Immunol. 2008, 253, 54-58.
44. Geissmann, F., Revy, P., Regnault, A., Lepelletier, Y. et al., TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells. J. Immunol. 1999, 162, 4567-4575.
45. Verhasselt, V., Vanden Berghe, W., Vanderheyde, N., Willems, F. et al., N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kappaB inhibition. J. Immunol. 1999, 162, 2569-2574.
46. Deluca, H.F., Cantorna, M.T., Vitamin D: its role and uses in immunology. FASEB J. 2001, 15, 2579-2585.
47. Hewison, M., Freeman, L., Hughes, S.V., Evans, K.N. et al., Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 2003, 170, 5382-5390.
48. Overbergh, L., Decallonne, B., Valckx, D., Verstuyf, A. et al., Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin. Exp. Immunol. 2000, 120, 139-146.
49. Penna, G., Adorini, L., 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 2000, 164, 2405-2411.
50. Penna, G., Amuchastegui, S., Giarratana, N., Daniel, K.C. et al., 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J. Immunol. 2007, 178, 145-153.
51. Figdor, C.G., de Vries, I.J., Lesterhuis, W.J., Melief, C.J., Dendritic cell immunotherapy: mapping the way. Nat. Med. 2004, 10, 475-480.
52. Reinhard, G., Marten, A., Kiske, S.M., Feil, F. et al., Generation of dendritic cell-based vaccines for cancer therapy. Br. J. Cancer 2002, 86, 1529-1533.
53. Lim, D.S., Kang, M.S., Jeong, J.A., Bae, Y.S., Semimature DC are immunogenic and not tolerogenic when inoculated at a high dose in collagen-induced arthritis mice. Eur. J. Immunol. 2009, 39, 1334-1343.
54. Ahn, J.H., Lee, Y., Jeon, C., Lee, S.J. et al., Identification of the genes differentially expressed in human dendritic cell subsets by cDNA subtraction and microarray analysis. Blood 2002, 100, 1742-1754.
55. Baltathakis, I., Alcantara, O., Boldt, D.H., Expression of different NF-kappaB pathway genes in dendritic cells (DCs) or macrophages assessed by gene expression profiling. J. Cell Biochem. 2001, 83, 281-290.
56. Chen, Z., Gordon, J.R., Zhang, X., Xiang, J., Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays. Biochem. Biophys. Res. Commun. 2002, 290, 66-72.
57. Ju, X.S., Hacker, C., Madruga, J., Kurz, S.M. et al., Towards determining the differentiation program of antigen-presenting dendritic cells by transcriptional profiling. Eur. J. Cell Biol. 2003, 82, 75-86.
58. Hashimoto, S., Suzuki, T., Dong, H.Y., Nagai, S. et al., Serial analysis of gene expression in human monocyte-derived dendritic cells. Blood 1999, 94, 845-852.
59. Huang, Q., Liu, D., Majewski, P., Schulte, L.C. et al., The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294, 870-875.
60. Tang, Z., Saltzman, A., Understanding human dendritic cell biology through gene profiling. Inflamm. Res. 2004, 53, 424-441.
61. Ferreira, G.B., Overbergh, L., Van Etten, E., Lage, K. et al., Protein-induced changes during the maturation process of human dendritic cells: 2-D DIGE approach. Proteomics Clin. Appl. 2008, 2, 1349-1360.
62. Horlock, C., Shakib, F., Mahdavi, J., Jones, N.S. et al., Analysis of proteomic profiles and functional properties of human peripheral blood myeloid dendritic cells, monocyte-derived dendritic cells and the dendritic cell-like KG-1 cells reveals distinct characteristics. Genome Biol. 2007, 8, R30.
63. Le Naour, F., Hohenkirk, L., Grolleau, A., Misek, D.E. et al., Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 2001, 276, 17920-17931.
64. Richards, J., Le Naour, F., Hanash, S., Beretta, L., Integrated genomic and proteomic analysis of signaling pathways in dendritic cell differentiation and maturation. Ann. NY Acad. Sci. 2002, 975, 91-100.
65. Rivollier, A., Perrin-Cocon, L., Luche, S., Diemer, H. et al., High expression of antioxidant proteins in dendritic cells: possible implications in atherosclerosis. Mol. Cell Proteomics 2006, 5, 726-736.
66. Watarai, H., Hinohara, A., Nagafune, J., Nakayama, T. et al., Plasma membrane-focused proteomics: dramatic changes in surface expression during the maturation of human dendritic cells. Proteomics 2005, 5, 4001-4011.
67. Angenieux, C., Fricker, D., Strub, J.M., Luche, S. et al., Gene induction during differentiation of human monocytes into dendritic cells: an integrated study at the RNA and protein levels. Funct. Integr. Genomics. 2001, 1, 323-329.
68. Pereira, S.R., Faca, V.M., Gomes, G.G., Chammas, R. et al., Changes in the proteomic profile during differentiation and maturation of human monocyte-derived dendritic cells stimulated with granulocyte macrophage colony stimulating factor/interleukin-4 and lipopolysaccharide. Proteomics 2005, 5, 1186-1198.
69. Phipps, R.P., Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc. Natl. Acad. Sci. USA 2000, 97, 6930-6932.
70. Yilmaz, A., Lochno, M., Traeg, F., Cicha, I. et al., Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004, 176, 101-110.
71. St Louis, D.C., Woodcock, J.B., Franzoso, G., Blair, P.J. et al. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. J. Immunol. 1999, 162, 3237-3248.
72. Al-Alwan, M.M., Rowden, G., Lee, T.D., West, K.A., Fascin is involved in the antigen presentation activity of mature dendritic cells. J. Immunol. 2001, 166, 338-345.
73. Al-Alwan, M.M., Liwski, R.S., Haeryfar, S.M., Baldridge, W.H. et al., Cutting edge: dendritic cell actin cytoskeletal polarization during immunological synapse formation is highly antigen-dependent. J. Immunol. 2003, 171, 4479-4483.
74. Huber, L.A., Pfaller, K., Vietor, I., Organelle proteomics: implications for subcellular fractionation in proteomics. Circ. Res. 2003, 92, 962-968.
75. Johnstone, R.M., Adam, M., Hammond, J.R., Orr, L. et al., Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 1987, 262, 9412-9420.
76. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J. et al., Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 1998, 4, 594-600.
77. Hwang, I., Huang, J.F., Kishimoto, H., Brunmark, A. et al., T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 2000, 191, 1137-1148.
78. Knight, S.C., Iqball, S., Roberts, M.S., Macatonia, S. et al., Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation. Eur. J. Immunol. 1998, 28, 1636-1644.
79. Andre, F., Chaput, N., Schartz, N.E., Flament, C. et al., Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol. 2004, 172, 2126-2136.
80. Thery, C., Duban, L., Segura, E., Veron, P. et al., Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat. Immunol. 2002, 3, 1156-1162.
81. Segura, E., Amigorena, S., Thery, C., Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol. Dis. 2005, 35, 89-93.
82. Thery, C., Boussac, M., Veron, P., Ricciardi-Castagnoli, P. et al., Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 2001, 166, 7309-7318.
83. Thery, C., Regnault, A., Garin, J., Wolfers, J. et al., Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J. Cell Biol. 1999, 147, 599-610.
84. Gundacker, N.C., Haudek, V.J., Wimmer, H., Slany, A. et al., Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells. J. Proteome. Res. 2009, 8, 2799-2811.
85. Chevallet, M., Diemer, H., Van Dorssealer, A., Villiers, C. et al., Toward a better analysis of secreted proteins: the example of the myeloid cells secretome. Proteomics 2007, 7, 1757-1770.
86. Steinbrink, K., Mahnke, K., Grabbe, S., Enk, A.H. et al., Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance? Hum. Immunol. 2009, 70, 289-293.
87. Jonuleit, H., Schmitt, E., Steinbrink, K., Enk, A.H., Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001, 22, 394-400.
88. Reynolds, J.L., Mahajan, S.D., Sykes, D.E., Schwartz, S.A. et al., Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim. Biophys. Acta 2007, 1774, 433-442.
89. Boddiger, D., Metamphetamine use linked to rising HIV transmission. Lancet 2005, 365, 1217-1218.
90. Frosch, D., Shoptaw, S., Huber, A., Rawson, R.A. et al., Sexual HIV risk among gay and bisexual male methamphetamine abusers. J. Subst. Abuse Treat. 1996, 13, 483-486.
91. Urbina, A., Jones, K., Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin. Infect. Dis. 2004, 38, 890-894.
92. Ouellet, M., Mercier, S., Pelletier, I., Bounou, S. et al., Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J. Immunol. 2005, 174, 4120-4126.
93. Rhee, S.G., Chae, H.Z., Kim, K., Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 2005, 38, 1543-1552.
94. Weng, Y.Q., Qiu, S.J., Liu, Y.K., Fan, J. et al., Downregulation of beta-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study. J. Cancer Res. Clin. Oncol. 2008, 134, 179-186.
95. Horlock, C., Shakib, F., Jones, N.S., Sewell, H.F. et al., Differential Protein Expression by Dendritic Cells from Atopic and Non-Atopic Individuals after Stimulation by the Major House Dust Mite Allergen Der p 1. Int. Arch. Allergy Immunol. 2009, 150, 237-251.
96. Arend, W.P., Malyak, M., Guthridge, C.J., Gabay, C., Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 1998, 16, 27-55.
97. Je, J.H., Lee, T.H., Kim, D.H., Cho, Y.H. et al., Mitochondrial ATP synthase is a target for TNBS-induced protein carbonylation in XS-106 dendritic cells. Proteomics 2008, 8, 2384-2393.
98. Wang, C.Y., Staniforth, V., Chiao, M.T., Hou, C.C. et al., Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cells. BMC Genomics 2008, 9, 479.
99. Matthias, A., Banbury, L., Bone, K.M., Leach, D.N. et al., Echinacea alkylamides modulate induced immune responses in T-cells. Fitoterapia 2008, 79, 53-58.
100. Matthias, A., Banbury, L., Stevenson, L.M., Bone, K.M. et al., Alkylamides from echinacea modulate induced immune responses in macrophages. Immunol. Invest. 2007, 36, 117-130.
101. Zhai, Z., Liu, Y., Wu, L., Senchina, D.S. et al., Enhancement of innate and adaptive immune functions by multiple Echinacea species. J. Med. Food 2007, 10, 423-434.
102. Bauer, V.R., Jurcic, K., Puhlmann, J., Wagner, H., [Immunologic in vivo and in vitro studies on Echinacea extracts]. Arzneimittelforschung 1988, 38, 276-281.
103. Sharma, M., Arnason, J.T., Burt, A., Hudson, J.B., Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells. Phytother. Res. 2006, 20, 147-152.
104. Wang, C.Y., Chiao, M.T., Yen, P.J., Huang, W.C. et al., Modulatory effects of Echinacea purpurea extracts on human dendritic cells: a cell- and gene-based study. Genomics 2006, 88, 801-808.
105. Lee, J.A., Sung, H.N., Jeon, C.H., Gill, B.C. et al., AIP1, a carbohydrate fraction from Artemisia iwayomogi, modulates the functional differentiation of bone marrow-derived dendritic cells. Int. Immunopharmacol. 2008, 8, 534-541.
106. Koo, K.A., Kwak, J.W., Lee, K.R., Zee, O.P. et al., Antitumor and immuno-modulating activities of the polyssacharide fractions from Artemisia selengenesis and Artemisia iwayomogi. Arch. Pharm. Res. 1994, 17, 371-374.
107. D'Ambrosio, D., Cippitelli, M., Cocciolo, M.G., Mazzeo, D. et al., Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 1998, 101, 252-262.
108. Piemonti, L., Monti, P., Sironi, M., Fraticelli, P. et al., Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000, 164, 4443-4451.
109. Ferreira, G.B., van Etten, E., Lage, K., Hansen, D.A. et al., Proteome analysis demosntrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D. Proteomics 2009, 9, 3752-3764.
110. Ferret-Bernard, S., Curwen, R.S., Mountford, A.P., Proteomic profiling reveals that Th2-inducing dendritic cells stimulated with helminth antigens have a 'limited maturation' phenotype. Proteomics 2008, 8, 980-993.
111. Futcher, B., Latter, G.I., Monardo, P., McLaughlin, C.S. et al., A sampling of the Yeast Proteome. Mol. Cell Biol. 1999, 19, 7357-7368.
112. Gygi, S.P., Rochon, Y., Franza, B.R., Aebersold, R., Correlation between protein and mRNA abundance in yeast. Mol. Cell Biol. 1999, 19, 1720-1730.
113. Pennington, S.R., Dunn, M.J., (Eds.), Proteomics: From Protein sequence to function. BIOS Scientific Publishers Limited, Oxford 2001.
114. Kruger, M., Moser, M., Ussar, S., Thievessen, I. et al., SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function. Cell 2008, 134, 353-364.
115. Schulz-Knappe, P., Zucht, H.D., Heine, G., Jurgens, M. et al., Peptidomics: the comprehensive analysis of peptides in complex biological mixtures. Comb. Chem. High Throughput Screen 2001, 4, 207-217.
116. Schmelzle, K., White, F.M., Phosphoproteomic approaches to elucidate cellular signaling networks. Curr. Opin. Biotechnol. 2006, 17, 406-414.
117. Diks, S.H., Peppelenbosch, M.P., Single cell proteomics for personalised medicine. Trends Mol. Med. 2004, 10, 574-577.